文献速递肝病

确定肝移植候选者等待名单死亡率的肝衰弱指数最佳截断值

Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates.
PubMed 文献 · Hepatology · 2020-10-30

研究纳入美国九个肝移植中心1405例无肝细胞癌的等待肝移植肝硬化成人,采用多变量竞争风险分析评估肝衰弱指数(LFI)与等待名单死亡率的关系,并寻找最佳截断值。结果显示LFI在3.7-5.2范围内可预测等待名单死亡率,3个月最佳截断值为4.4,6个月和12个月均为4.2;LFI联合MELDNa对3个月死亡率的预测AUC为0.79,优于单用MELDNa的0.73。

要点

  • LFI在3.7-5.2范围内可预测肝移植等待名单死亡率。
  • 3个月等待名单死亡率的最佳LFI截断值为4.4,6个月和12个月均为4.2。
  • LFI联合MELDNa预测3个月死亡率的AUC为0.79,高于单用MELDNa的0.73。

核心结论

  • LFI在广泛的LFI值范围内可预测等待名单死亡率。
  • 等待名单死亡率的最佳LFI截断值在3个月为4.4,在6个月和12个月为4.2。
  • LFI联合MELDNa的判别性能优于单用MELDNa。
  • 作者认为将LFI与MELDNa结合可更准确地反映肝移植候选者的等待名单死亡率。

研究设计与样本

  • 研究纳入美国九个肝移植中心等待肝移植、无肝细胞癌且接受LFI评估的肝硬化成人,共1405例。
  • 采用多变量竞争风险分析评估LFI与等待名单死亡率的关系。
  • 通过评估竞争风险模型的拟合度(以伪对数似然判断)确定单一LFI截断值。
  • 通过等待名单死亡率分析的曲线下面积(AUC)确定3、6或12个月的最佳截断值。
  • 采用AUC比较LFI联合终末期肝病模型-钠(MELDNa)与单用MELDNa对3个月等待名单死亡率的预测能力。

主要发现

  • 1405例患者中,3个月、6个月和12个月分别有37例(3%)、82例(6%)和135例(10%)发生等待名单死亡。
  • LFI在3.7-5.2的广泛范围内可预测等待名单死亡率。
  • 3个月死亡率的最佳LFI截断值为4.4(95%CI 4.0-4.8),6个月为4.2(95%CI 4.1-4.4),12个月为4.2(95%CI 4.1-4.4)。
  • 预测3个月死亡率时,MELDNa的AUC为0.73,加入LFI后AUC提高至0.79。

关键数值与推荐

  • 3个月等待名单死亡率的最佳LFI截断值为4.4(95%CI 4.0-4.8)。
  • 6个月等待名单死亡率的最佳LFI截断值为4.2(95%CI 4.1-4.4)。
  • 12个月等待名单死亡率的最佳LFI截断值为4.2(95%CI 4.1-4.4)。
  • 预测3个月死亡率:单用MELDNa的AUC为0.73,LFI联合MELDNa的AUC为0.79。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Frailty, as measured by the Liver Frailty Index (LFI), is associated with liver transplant (LT) waitlist mortality. We sought to identify an optimal LFI cutoff that predicts waitlist mortality. APPROACH AND RESULTS: Adults with cirrhosis awaiting LT without hepatocellular carcinoma at nine LT centers in the United States with LFI assessments were included. Multivariable competing risk analysis assessed the relationship between LFI and waitlist mortality. We identified a single LFI cutoff by evaluating the fit of the competing risk models, searching for the cutoff that gave the best model fit (as judged by the pseudo-log-likelihood). We ascertained the area under the curve (AUC) in an analysis of waitlist mortality to find optimal cutoffs at 3, 6, or 12 months. We used the AUC to compare the discriminative ability of LFI+Model for End Stage Liver Disease-sodium (MELDNa) versus MELDNa alone in 3-month waitlist mortality prediction. Of 1,405 patients, 37 (3%), 82 (6%), and 135 (10%) experienced waitlist mortality at 3, 6, and 12 months, respectively. LFI was predictive of waitlist mortality across a broad LFI range: 3.7-5.2. We identified an optimal LFI cutoff of 4.4 (95% confidence interval [CI], 4.0-4.8) for 3-month mortality, 4.2 (95% CI, 4.1-4.4) for 6-month mortality, and 4.2 (95% CI, 4.1-4.4) for 12-month mortality. The AUC for prediction of 3-month mortality for MELDNa was 0.73; the addition of LFI to MELDNa improved the AUC to 0.79. CONCLUSIONS: LFI is predictive of waitlist mortality across a wide spectrum of LFI values. The optimal LFI cutoff for waitlist mortality was 4.4 at 3 months and 4.2 at 6 and 12 months. The discriminative performance of LFI+MELDNa was greater than MELDNa alone. Our data suggest that incorporating LFI with MELDNa can more accurately represent waitlist mortality in LT candidates.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Kardashian A, Ge J, McCulloch CE, et al. Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates. Hepatology. 2020. PMID: 32491208. doi:10.1002/hep.31406

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。